At the news
? NEUTRALIMPACT 2/10 3 filed Jul 6, 2026 at 11:31 ET
Bruce Broussard filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd. The filing also includes a power of attorney authorizing legal counsel to execute future Section 16 filings. This is a routine administrative filing by a new insider and has no material impact on the company's operations or financials.
- Bruce Broussard filed a Form 3 initial statement of beneficial ownership
- Reports beneficial ownership of 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd
- Filing includes a power of attorney for Section 16 and Rule 144 filings
- No material financial data, guidance, or operational changes disclosed
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access